Improving the Carrier Stability and Drug Loading of Unimolecular Micelle-Based Nanotherapeutics for Acid-Activated Drug Delivery and Enhanced Antitumor Therapy

Xiaoxiao Shi,Shuang Bai,Cangjie Yang,Xiaoqian Ma,Meili Hou,Jiucun Chen,Peng Xue,Chang Ming Li,Yuejun Kang,Zhigang Xu
DOI: https://doi.org/10.1039/c8tb01384e
IF: 7.571
2018-01-01
Journal of Materials Chemistry B
Abstract:Nanomedicines based on unimolecular micelles (UMs) have shown unique advantages such as high micellar stability, programmed cargo delivery and enhanced therapeutic efficiency. Herein, we report an acid-activated amphiphilic prodrug based on a dextran (DEX) polymeric framework (DEX-PDOX-b-POEGMA, labelled DMO@DOX), which conjugates a diblock copolymer of a hydrophobic doxorubicin (DOX) prodrug block and a hydrophilic poly[oligo(ethylene glycol) methyl ether methacrylate] (POEGMA) block by atom transfer radical polymerization. The DMO@DOX prodrug can form nano-sized UMs in aqueous media attributed to its amphiphilic structure and achieve a very high drug loading rate of 80.4 wt%. In the presence of an acidic medium resembling a tumor microenvironment, the hydrazone bond embedded in the prodrug is broken, which releases the loaded drug of DOX. The DMO@DOX prodrug shows a notable and preferential inhibition effect on the growth of tumor cells in vitro compared to healthy cells, leading to advantageous biocompatibility and effective antitumor activity. For verification, the DMO@DOX prodrug was applied in the treatment of a mouse model bearing xenograft tumors and showed a remarkable therapeutic performance. This study demonstrates an effective design of UM-based nanoagents to improve the micellar stability of polymeric prodrug micelles with enhanced performance in cancer therapy.
What problem does this paper attempt to address?